Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Clinical trial NCT03338920 · TERMINATED
Trial details
- NCT number
- NCT03338920
- Sponsor
- Currax Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2022-04-11
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.